Atlas Trials

JDB153 Combined With Penpulimab for Hepatocellular Carcinoma After Standard Treatment Failure

Clinical trial NCT07075419 · NOT_YET_RECRUITING

Trial details

NCT number
NCT07075419
Sponsor
West China Hospital
Status
NOT_YET_RECRUITING
Phase
Phase 1, Phase 2
Study type
INTERVENTIONAL
Refractory Hepatocellular Carcinoma
Start date
2025-08-01
Primary completion
2027-07-01
Enrollment
10

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.